n-(2-hydroxypropyl)methacrylamide has been researched along with Burkitt Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gudheti, M; Hartley, JM; Kopeček, J; Yang, J; Zhang, R | 1 |
Etrych, T; Kabesová, M; Kovár, L; Ríhová, B; Strohalm, J; Ulbrich, K | 1 |
2 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Burkitt Lymphoma
Article | Year |
---|---|
Tracking and quantifying polymer therapeutic distribution on a cellular level using 3D dSTORM.
Topics: Burkitt Lymphoma; Cell Line, Tumor; Drug Delivery Systems; Female; Fluorescent Dyes; Humans; Microscopy; Nanoconjugates; Optical Imaging; Ovarian Neoplasms; Peptides; Polymethacrylic Acids | 2016 |
HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Burkitt Lymphoma; Cell Line, Tumor; Cytostatic Agents; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Lymphoma, T-Cell; Male; Methacrylates; Mice; Models, Chemical; Molecular Weight; Polymers; Solubility; Water | 2009 |